ANI Pharmaceuticals, Inc. (ANIP) Operating cash flow 2016–2025
ANI Pharmaceuticals, Inc. (ANIP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$185.2MFY2025 · since FY2016: $27.5M → $185.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $185.2M | +189.3% |
| FY2024 | $64.0M | -46.2% |
| FY2023 | $119.0M | +481.2% |
| FY2022 | -$31.2M | -1039.3% |
| FY2021 | $3.3M | -78.2% |
| FY2020 | $15.3M | -66.5% |
| FY2019 | $45.6M | -32.0% |
| FY2018 | $67.1M | +70.2% |
| FY2017 | $39.4M | +43.5% |
| FY2016 | $27.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice